EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
基本信息
- 批准号:7489425
- 负责人:
- 金额:$ 73.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-05-15 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAgingAging-Related ProcessBinding ProteinsBiological AgingBiological MarkersBirth WeightBlood PressureC-reactive proteinCardiacCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemChildChildhoodCohort StudiesCommunitiesComplexDataDatabasesDimensionsDiseaseDoctor of MedicineEnvironmental Risk FactorEvolutionFamily history ofFamily memberFemaleFibrinogenGeneticGenomicsGestational AgeGlucoseGrantHeartHomocysteineHomocystineIndividualInflammationInsulinInsulin-Like Growth Factor IIntercellular adhesion molecule 1Interleukin-6Left ventricular structureLengthLeukocytesLifeLipoproteinsLongevityLow Birth Weight InfantMeasuresMediator of activation proteinMetabolic Syndrome XMetabolic syndromeMonitorMorbidity - disease rateNatural HistoryNatural ResourcesObesityOutcome MeasureOxidative StressPhysiologic pulsePlasminogen InactivatorsPopulationPredisposing FactorPredispositionPremature MortalityPrevention strategyProcessPulse takingRaceRateRecording of previous eventsResearchResourcesRiskRisk FactorsSomatic CellStructureTimeVariantadiponectinage effectbasebody systembrachial arterycardiovascular risk factorcohortdimorphismheart dimension/sizein uteroindexingmalemiddle agemortalitynormal agingsexual dimorphismtelomeretrait
项目摘要
DESCRIPTION (provided by applicant): The cardiovascular (C-V) system is a vital organ system most affected by the aging process. The natural history of C-V aging in terms of arterial and cardiac structure/function (C-V indices) is governed by a complex interplay between an intrinsic (biologic) aging effect and a burden of C-V risk factors beginning early in life. This renewal application focuses on the pathobiological traits associated with C-V aging in a community-based, black-white, middle-aged cohort having been followed over 30 years beginning in childhood. The specific aims are to 1) continue monitoring the progression of C-V indices with respect to chronological age, the burden of C-V risk factor variables and familial traits of C-V risk and longevity; 2) determine the relationship between changes in C-V indices and biological aging ascertained by chromosomal telomere dynamics; 3) examine the influence of birth weight on the burden of C-V risk factor variables since childhood and the rate of adverse changes in C-V indices. The ongoing study cohort followed during the previous grant period (Cohort I, n=1,200) and an additional cohort examined as children 10 years ago (Cohort II, n=1,200) are available to achieve these aims. In addition to telomere dynamics, birth weight, and subclinical C-V indices, data on selected key variables relevant to C-V aging, in particular risk variables of metabolic syndrome including inflammation and oxidative stress will be collected. Both cohorts will be examined for 1) C-V indices by carotid IMT, left ventricular structure and function, brachial artery compliance, and arterial pulse wave velocity; 2) C-V risk factor variables comprising obesity measures, blood pressure, lipoprotein variables, glucose, insulin, and parameters of oxidative stress; and 3) telomere length. In addition, data on birth weight, adiponectin, insulin like growth factor-I and binding proteins, homocysteine, fibrinogen, plasminogen activator inhibitor-I, C-reactive protein, interleukin-6, and intercellular adhesion molecule-1 will be obtained in Cohort I; telomere attrition rate from childhood to adulthood and familial traits of C-V risk and longevity in Cohort I1. The extensive serial database of the Bogalusa Heart Study provides unique and valuable resources. Findings from the proposed research will further the understanding of C-V aging and predisposing factors that influence aging in a bi-racial young to middle age population. Observations derived from this research will help develop effective preventive strategies to temper mediators that influence premature C-V morbidity and mortality.
描述(由申请人提供):心血管(C-V)系统是受衰老过程影响最大的重要器官系统。在动脉和心脏结构/功能(C-V指数)方面,C-V衰老的自然历史受固有(生物学)衰老效应的复杂相互作用与从生命早期开始的C-V风险因素负担之间的复杂相互作用。这种更新应用的重点是与C-V衰老相关的病理学特征,在童年开始的30年以上,遵循了30年的社区,黑白,中年队列。具体目的是1)继续监视C-V指数的进展,相对于年龄,C-V风险因素变量的负担以及C-V风险和寿命的家族性状的负担; 2)确定C-V指数变化与染色体端粒动力学确定的生物老化之间的关系; 3)检查出生体重自儿时以来C-V风险因素变量负担的影响以及C-V指数不良变化的率。正在进行的研究队列遵循上一个赠款期(队列I,n = 1,200)和10年前的儿童(同类II,n = 1,200)检查的其他队列可用于实现这些目标。除了端粒动力学,出生体重和亚临床C-V指数外,还将收集与C-V衰老相关的选定关键变量的数据,特别是代谢综合征的风险变量,包括炎症和氧化应激。将通过颈动脉IMT,左心室结构和功能,臂动脉依从性和动脉脉冲波速度检查两个队列的1)C-V指数。 2)C-V风险因素变量包括肥胖症测量,血压,脂蛋白变量,葡萄糖,胰岛素和氧化应激的参数; 3)端粒长度。 此外,在同胞I中将获得有关出生体重,脂联素,胰岛素(如生长因子I)和结合蛋白,同型半胱氨酸,纤维蛋白原,纤维蛋白原激活剂抑制剂I,C反应蛋白,白介素6和细胞间粘附分子1的数据。从童年到成年期的端粒损耗率以及C-V风险和寿命I1的家族性质。 Bogalusa心脏研究的广泛序列数据库提供了独特而有价值的资源。拟议的研究的结果将进一步了解C-V衰老和易于影响的因素,这些因素会影响双种族年轻人至中年人口的衰老。 这项研究得出的观察结果将有助于制定有效的预防策略,以调节影响过早C-V发病率和死亡率的调解人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GERALD Sanders BERENSON其他文献
GERALD Sanders BERENSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GERALD Sanders BERENSON', 18)}}的其他基金
Evolution of Cardiovascular Risk with Normal Aging
正常衰老过程中心血管风险的演变
- 批准号:
8436938 - 财政年份:2012
- 资助金额:
$ 73.8万 - 项目类别:
Evolution of Cardiovascular Risk with Normal Aging
正常衰老过程中心血管风险的演变
- 批准号:
8723711 - 财政年份:2012
- 资助金额:
$ 73.8万 - 项目类别:
Evolution of Cardiovascular Risk with Normal Aging
正常衰老过程中心血管风险的演变
- 批准号:
8548213 - 财政年份:2012
- 资助金额:
$ 73.8万 - 项目类别:
Evaluation of Cardiovascular Health Among Residents
居民心血管健康状况评价
- 批准号:
7044023 - 财政年份:2003
- 资助金额:
$ 73.8万 - 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:
6372298 - 财政年份:2000
- 资助金额:
$ 73.8万 - 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:
7119557 - 财政年份:2000
- 资助金额:
$ 73.8万 - 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:
7288588 - 财政年份:2000
- 资助金额:
$ 73.8万 - 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:
7918134 - 财政年份:2000
- 资助金额:
$ 73.8万 - 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:
6792730 - 财政年份:2000
- 资助金额:
$ 73.8万 - 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:
6053741 - 财政年份:2000
- 资助金额:
$ 73.8万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
- 批准号:31470998
- 批准年份:2014
- 资助金额:87.0 万元
- 项目类别:面上项目
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 73.8万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 73.8万 - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
$ 73.8万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 73.8万 - 项目类别:
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 73.8万 - 项目类别: